Beneficial effects seen for 12 weekly sessions of cognitive behavioral therapy and\/or pharmacotherapy using stepped approach <\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, June 23, 2023 (HealthDay News) — A technology-assisted stepped collaborative care intervention can reduce fatigue and pain among patients with end-stage kidney disease (ESKD) undergoing hemodialysis, according to a study published online June 20 in JAMA Internal Medicine<\/em>.<\/p>\n Manisha Jhamb, M.D., M.P.H., from the University of Pittsburgh School of Medicine, and colleagues compared the effectiveness of a stepped collaborative care intervention versus health education control for reducing fatigue, pain, and depression among ESKD patients undergoing long-term hemodialysis. The intervention group received 12 weekly sessions of cognitive behavioral therapy (CBT) delivered via telehealth and\/or pharmacotherapy using a stepped approach in collaboration with dialysis and primary care teams, while the attention control group received six health education telehealth sessions (83 and 77 patients, respectively).<\/p>\n The researchers found that patients in the intervention group experienced statistically and clinically significant reductions in fatigue and pain severity at three months compared with controls in the intention-to-treat analyses (mean difference, 2.81 and \u00e2\u0088\u00920.96, respectively). At six months, these effects were sustained (mean difference, 3.73 and \u00e2\u0088\u00921.49, respectively). At three months, there was a statistically significant but small improvement seen in depression (mean difference, \u00e2\u0088\u00921.73). Both groups had similar adverse events.<\/p>\n “Our results showed that among patients undergoing hemodialysis, a 12-week CBT-based stepped collaborative care intervention can offer clinically significant improvements in fatigue and pain,” the authors write.<\/p>\n Several authors disclosed ties to the biopharmaceutical industry.<\/p>\n